Pharmacological treatment with a Nur77 agonist in human urothelial cells in vitro blocked endocytosis and prevented UPEC intracellular invasion and limited UPEC UTI in vivo in the mouse model of UTI. Here, NR4A1 is linked to bacterial urinary tract infection.